Dr. Sankaran is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Longwood Avenue
Boston, MA 02115Phone+1 617-355-6000
Summary
- Dr. Vijay Sankaran is a pediatric hematologist/oncologist in Boston, MA and is affiliated with multiple hospitals in the area, including Boston Children's Hospital, Dana-Farber Cancer Institute, Brigham and Women's Hospital, and the Beth Israel Deaconess Hospital. He received his medical degree from Harvard Medical School and has been in practice 12 years. He is experienced in pediatric hematology/oncology, including in thalassemia, sickle cell disease, bone marrow failure syndromes, genetic predisposition to blood cancers, and other disorders impacting hematopoiesis.
Education & Training
- Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2013 - 2015
- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2010 - 2013
- Harvard Medical SchoolClass of 2010
Certifications & Licensure
- MA State Medical License 2013 - 2026
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Pilot Phase I/II Study of Amino Acid Leucine in Treatment of Patients With Transfusion-Dependent Diamond Blackfan Anemia Start of enrollment: 2013 Jun 01
Publications & Presentations
PubMed
- Genomic and phenotypic correlates of mosaic loss of chromosome Y in blood.Yasminka A Jakubek, Xiaolong Ma, Adrienne M Stilp, Fulong Yu, Jason Bacon
American Journal of Human Genetics. 2025-01-06 - 1 citationsRegulated GATA1 expression as a universal gene therapy for Diamond-Blackfan anemia.Richard A Voit, Xiaotian Liao, Alexis Caulier, Mateusz Antoszewski, Blake Cohen
Cell Stem Cell. 2025-01-02 - CEBPA repression by MECOM blocks differentiation to drive aggressive leukemias.Travis J Fleming, Mateusz Antoszewski, Sander Lambo, Michael C Gundry, Riccardo Piussi
Biorxiv. 2024-12-30
Press Mentions
- A Universal Gene Therapy for Diamond-Blackfan Anemia Is Poised for Clinical TestingNovember 21st, 2024
- How a Leukemia Hijacks the Genes Needed by Blood Stem CellsDecember 19th, 2022
- What Caused the Blood Malignancies Linked to Gene Therapy for Sickle Cell Disease?February 15th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: